Literature DB >> 11513008

Residential and nursing home care of elderly people with cognitive impairment: prevalence, mortality and costs.

A Netten1, R Darton, A Bebbington, J Forder, P Brown, K Mummery.   

Abstract

Cognitive impairment among residents has considerable resource implications for both individuals and those responsible for publicly funded care. Two linked surveys were carried out in England: (1) a longitudinal study followed 2500 admissions to publicly funded care up to 42 months after admission; and (2) a cross-sectional survey of 618 homes collected information about 11,900 residents. Information was collected about cognitive impairment using the Minimum Data Set Cognitive Performance Scale. Cognitive impairment was associated with source of funding and type of home. Although level of cognitive impairment has some effect, fees and costs were most influenced by type of home. At the same level of impairment, self-funded residents were more likely to be located in relatively low-cost settings than publicly funded residents. In independent homes fees were lower for publicly funded than for self-funded residents. Overall median length of stay of publicly funded admissions was 18 months. For the most part length of stay was not associated with level of cognitive impairment on admission. It is concluded that more information is needed about the effect of quality of care on people with cognitive impairment in different settings. If the same quality of care can be achieved in residential and nursing homes, the evidence would suggest that changes in placement policies could result in potential savings to the public purse.

Entities:  

Mesh:

Year:  2001        PMID: 11513008     DOI: 10.1080/13607860020020591

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  6 in total

1.  Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.

Authors:  Colin Green; Joanna Picot; Emma Loveman; Andrea Takeda; Jo Kirby; Andrew Clegg
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  The cost-effectiveness of multi-component interventions to prevent delirium in older people undergoing surgical repair of hip fracture.

Authors:  Anayo Akunne; Sarah Davis; Maggie Westby; John Young
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-02-15

Review 3.  A systematic review of the clinical and cost-effectiveness of memantine in patients with moderately severe to severe Alzheimer's disease.

Authors:  Joanna Kirby; Colin Green; Emma Loveman; Andrew Clegg; Joanna Picot; Andrea Takeda; Elizabeth Payne
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Consent processes in cluster-randomised trials in residential facilities for older adults: a systematic review of reporting practices and proposed guidelines.

Authors:  Karla Diazordaz; Anne-Marie Slowther; Rachel Potter; Sandra Eldridge
Journal:  BMJ Open       Date:  2013-07-08       Impact factor: 2.692

5.  Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register.

Authors:  Martin Knapp; Kia-Chong Chua; Matthew Broadbent; Chin-Kuo Chang; Jose-Luis Fernandez; Dominique Milea; Renee Romeo; Simon Lovestone; Michael Spencer; Gwilym Thompson; Robert Stewart; Richard D Hayes
Journal:  BMJ Open       Date:  2016-11-18       Impact factor: 2.692

6.  Groningen Frailty Indicator-Chinese (GFI-C) for pre-frailty and frailty assessment among older people living in communities: psychometric properties and diagnostic accuracy.

Authors:  Emma Yun Zhi Huang; Jasmine Cheung; Justina Yat Wa Liu; Rick Yiu Cho Kwan; Simon Ching Lam
Journal:  BMC Geriatr       Date:  2022-10-07       Impact factor: 4.070

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.